Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Antiviral Research|January 1, 1993
Studies on the effect of CL 306,293, a substituted quinoline carboxylic acid, on the clinical disease induced in mice with LP-BM5 virusJ W Scott, S Q DeJoy, R Jeyaseelan, et al.Cellular Immunology|October 15, 1995
Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2W Munger, S Q DeJoy, R Jeyaseelan, et al.Antimicrobial Agents and Chemotherapy|September 1, 1992
Studies of the effect of a platelet-activating factor antagonist, CL 184,005, in animal models of gram-negative bacterial sepsisL W Torley, W C Pickett, M L Carroll, et al.Cancer Research|April 15, 1992
Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolismA Rosowsky, J Galivan, G P Beardsley, et al.Journal of Virology|May 1, 1987
Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responsesJ W Torseth, G H Cohen, R J Eisenberg, et al.Journal of Medicinal Chemistry|December 25, 1992
Analogues of platelet activating factor. 7. Bis-aryl amide and bis-aryl urea receptor antagonists of PAFA Wissner, M L Carroll, B D Johnson, et al.Nature|July 21, 1994
Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processingK M Mohler, P R Sleath, J N Fitzner, et al.Journal of Medicinal Chemistry|September 17, 1993
Preparation of substituted N-phenyl-4-aryl-2-pyrimidinamines as mediator release inhibitorsR Paul, W A Hallett, J W Hanifin, et al.The Journal of Biological Chemistry|November 20, 1997
CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferationE E Brooks, N S Gray, A Joly, et al.Pageof 7